Purchase Order 75N91021P00746

The Department of Defense's Defense Health Agency (DHA) awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call order to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $157,041.40 contract is for the delivery of four (4) treatment radiopharmaceutical LUTATHERA, a targeted radioligand therapy used for cancer treatment and diagnostic imaging. This order is part of a larger $26 million...

The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceuticals. The $45,829.20 contract, which is not set-aside, was awarded on March 1, 2024 and has a completion date of February 28, 2025. This order is placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and will provide the VA with radiopharmaceutical...

This contract was awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc., a specialty pharmaceutical manufacturer, to provide radiopharmaceuticals and supplies. The contract is a firm fixed price blanket purchase agreement (BPA) call with a potential value of $25,000.00 and a completion date of September 30, 2023. The products will be delivered to facilities in El Paso, Texas to support nuclear medicine diagnostic services for the Military Health System's 9.5 million beneficiaries....

This is a federal contract award issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceuticals. The $108,500 firm-fixed-price delivery order is for the radiopharmaceutical drug DOTATATE, which is used in nuclear medicine procedures. The contract is not set aside and is awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle....

This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The contract, worth up to $80,000.00, is for the delivery of various radiopharmaceuticals to military treatment facilities to support nuclear medicine diagnostic services for active duty...

RLS USA Inc., a foreign-owned, for-profit organization, has been awarded a definitive contract valued at $888,053.37 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17. The firm fixed price contract is for the delivery of radiopharmaceuticals with a period of performance through August 8, 2023. No set-aside designation was applied to this award to fulfill the VA's requirement for these medical isotopes. Place of performance will be in...

This federal contract award for RADIOPHARMACEUTICALS, valued at $300,586.28, was made by the Veterans Integrated Service Network 23 (VISN 23) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC. Cardinal Health 414, LLC is a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type, and an ultimate completion date of September 30, 2024. This award is not set...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 (VA - VHA) awarded a $3.5 million Firm Fixed Price definitive contract to Austin Nuclear Pharmacy Services LLC to provide radiopharmaceuticals. The place of performance will be in Temple, Texas and the contract period runs from August 9, 2023 through August 8, 2028. No subcontractors were identified. Radiopharmaceuticals are radioactive pharmaceuticals used in medical imaging and treatment...

The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $129,900 firm fixed price purchase order to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer, to provide GA-68 DOTATATE, a radiopharmaceutical product, with a completion date of June 18, 2020. This order was not set aside for any small business program. Advanced Accelerator Applications USA Inc. is a radiopharmaceutical company that specializes in targeted radioligand therapy and...

This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $84,800 contract is for the supply of an FDA-approved drug used in critical patient care procedures at the NIH Clinical Center's nuclear medicine department. The contract has an ultimate completion date of March 31, 2022 and...